Page 32 - பல்கலைக்கழகம் ஆஃப் பென்சில்வேனியா ஆரோக்கியம் அமைப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பல்கலைக்கழகம் ஆஃப் பென்சில்வேனியா ஆரோக்கியம் அமைப்பு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பல்கலைக்கழகம் ஆஃப் பென்சில்வேனியா ஆரோக்கியம் அமைப்பு Today - Breaking & Trending Today

Study suggests persons who recover from COVID-19 may need one vaccine dose

Study suggests persons who recover from COVID-19 may need one vaccine dose
On
By Sola Ogundipe
Those who have had COVID-19 may only need one vaccine dose, a new study suggests People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, but a little immune benefit after the second dose, according to new research from the Penn Institute of Immunology.
The findings, published in Science Immunology, suggest only a single vaccine dose may be needed to produce a sufficient antibody response.
The team found that those who did not have COVID-19 called COVID naïve did not have a full immune response until after receiving their second vaccine dose, reinforcing the importance of completing the two recommended doses for achieving strong levels of immunity. ....

South Africa , South African , Sola Ogundipe , Jeffrey Lurie , E John Wherry , Joel Embiid , David Blitzer , Josh Harris , Century Scholar Fund , University Of Pennsylvania Perelman School Medicine , Allen Institute For Immunology , Research On Coronavirus , Penn Institute Of Immunology , Department Of Systems Pharmacology , Cancer Research Institute , Chen Family Research Fund , Perelman School Of Medicine , University Of Pennsylvania Health System , Mark Foundation Fellowship , Penn Center , University Of Pennsylvania , Parker Institute For Cancer Immunotherapy , Upenn Immune Health , Kindly Share This Story , Penn Institute , Science Immunology ,

Ingredient in Indian long pepper shows promise against brain cancer in animal models

E-Mail
PHILADELPHIA Piperlongumine, a chemical compound found in the Indian Long Pepper plant (Piper longum), is known to kill cancerous cells in many tumor types, including brain tumors. Now an international team including researchers from the Perelman School of Medicine at the University of Pennsylvania has illuminated one way in which the piperlongumine works in animal models and has confirmed its strong activity against glioblastoma, one of the least treatable types of brain cancer.
The researchers, whose findings were published this month in
ACS Central Science, showed in detail how piperlongumine binds to and hinders the activity of a protein called TRPV2, which is overexpressed in glioblastoma in a way that appears to drive cancer progression. The scientists found that piperlongumine treatment radically shrank glioblastoma tumors and extended life in two mouse models of this cancer, and also selectively destroyed glioblastoma cells taken from human pati ....

Pennsylvania Hospital , United States , New Jersey , University Of Pennsylvania , United Kingdom , Agencia Estatal Investigaci , Vera Moiseenkova Bell , Tiago Rodrigues , Royal Society , Penn Medicine Princeton Health , University Of Lisbon , Lancaster Behavioral Health Hospital , Electron Microscopy Resource Laboratory , Perelman School Of Medicine , University Of Pennsylvania Health System , European Molecular Biology Organization Installation Grant , University Of Cambridge , Beckman Center , Ruth Perelman School Of Medicine , Hospital Of The University Pennsylvania , Research Council , European Union Horizon , National Institutes Of Health , Portuguese Foundation For Science , Institute Of Molecular Medicine , Princeton House Behavioral Health ,

New Publications Highlight Clinical Benefits of Avinger PAD Therapies

New Publications Highlight Clinical Benefits of Avinger PAD Therapies
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.

Redwood City , United States , University Of Pennsylvania , Jaafer Golzar , Matt Kreps , Jon George , Mark Weinswig , Avinger Inc , Division Of Cardiovascular Disease , Exchange Commission On , Einstein Medical Center , University Of Pennsylvania Health System , Securities Exchange , Darrow Associates Investor Relations , Peripheral Artery Disease , Cardiovascular Disease , Endovascular Medicine , Pennsylvania Health System , Chief Medical Officer , Critical Limb Ischemia , Single Center Experience , Below The Knee Critical Limb Ischemia , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Risk Factor ,

Avinger, Inc.: New Publications Highlight Clinical Benefits of Avinger PAD Therapies

Avinger, Inc.: New Publications Highlight Clinical Benefits of Avinger PAD Therapies
REDWOOD CITY, CA / ACCESSWIRE / April 21, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced the publication of two clinical studies in peer-reviewed journals, further supporting the clinical benefits of its therapeutic devices. The studies were based on separate clinical case series conducted by physicians at the Division of Cardiovascular Disease and Endovascular Medicine at the Einstein Medical Center in Philadelphia, Pennsylvania.
These two studies demonstrate the utility of Avinger s OCT-guided approach for the treatment of PAD in complex and challenging cases and patient populations, commented Dr. Jon George, an interventional cardiologist and endovascular specialist at the University of Pennsylvani ....

Redwood City , United States , University Of Pennsylvania , Jaafer Golzar , Matt Kreps , Jon George , Mark Weinswig , Avinger Inc , Division Of Cardiovascular Disease , Exchange Commission On , Einstein Medical Center , University Of Pennsylvania Health System , Securities Exchange , Darrow Associates Investor Relations , Peripheral Artery Disease , Cardiovascular Disease , Endovascular Medicine , Pennsylvania Health System , Chief Medical Officer , Critical Limb Ischemia , Center Experience , Below The Knee Critical Limb Ischemia , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Annual Report ,

Penn study finds that people who recovered from COVID-19 may only need one dose of the vaccine

Penn study finds that people who recovered from COVID-19 may only need one dose of the vaccine
thedp.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thedp.com Daily Mail and Mail on Sunday newspapers.

University Of Pennsylvania , United States , South Africa , South African , Olivia Haynie , Allen Institute For Immunology , Research On Coronavirus , Penn Institute Of Immunology , Cancer Research Institute , University Of Pennsylvania Health System , Mark Foundation Fellowship , Penn Center , Penn Institute , Penn Today , Pennsylvania Health System , Penn Medicine News , New England Journal , Philadelphia Inquirer , Science Immunology , Allen Institute , பல்கலைக்கழகம் ஆஃப் பென்சில்வேனியா , ஒன்றுபட்டது மாநிலங்களில் , ஒலிவியா ஹய்நிே , ஆலன் நிறுவனம் க்கு நோயெதிர்ப்பு , பென் நிறுவனம் ஆஃப் நோயெதிர்ப்பு , புற்றுநோய் ஆராய்ச்சி நிறுவனம் ,